A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice

A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer

(2014) G. S. Taylor et al.   CLINICAL CANCER RESEARCH

Animal models of Epstein Barr virus infection

(2014) Bithi Chatterjee et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Diagnosis and management of lymphomas and other cancers in HIV-infected patients

(2014) Antonino Carbone et al.   Nature Reviews Clinical Oncology

A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine

(2013) Xinle Cui et al.   VACCINE

Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor

(2013) Javier G. Ogembo et al.   Cell Reports

Three-dimensional structure of the Epstein-Barr virus capsid

(2012) R. Germi et al.   JOURNAL OF GENERAL VIROLOGY

Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen

(2012) A. Link et al.   JOURNAL OF IMMUNOLOGY

Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students

(2012) Henry H. Balfour et al.   JOURNAL OF INFECTIOUS DISEASES

An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA

(2012) S. Pavlova et al.   JOURNAL OF VIROLOGY

Structure and assembly of a paramyxovirus matrix protein

(2012) A. J. Battisti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Development and optimization of neutralizing antibody assays to monitor clinical immunogenicity

(2012) Francesca Civoli et al.   Bioanalysis

Virus-like particles induce robust human T-helper cell responses

(2011) Marion Braun et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

A Virus-Like Particle-Based Epstein-Barr Virus Vaccine

(2011) R. Ruiss et al.   JOURNAL OF VIROLOGY

Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

(2011) J. I. Cohen et al.   Science Translational Medicine

Vaccines to Prevent Infections by Oncoviruses

(2010) John T. Schiller et al.   Annual Review of Microbiology

Prevention of cancer by prophylactic human papillomavirus vaccines

(2010) Kihyuck Kwak et al.   CURRENT OPINION IN IMMUNOLOGY

Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins

(2010) L. W. McGinnes et al.   JOURNAL OF VIROLOGY

Infectious Mononucleosis

(2010) Katherine Luzuriaga et al.   NEW ENGLAND JOURNAL OF MEDICINE

Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology

(2009) M. R. Murawski et al.   JOURNAL OF VIROLOGY

Self-Assembly of Epstein-Barr Virus Capsids

(2009) B. W. Henson et al.   JOURNAL OF VIROLOGY

A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation

(2009) Lesley Rees et al.   TRANSPLANTATION

Human antibody titers to Epstein–Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay

(2009) Junji Sashihara et al.   VIROLOGY

Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1

(2008) I. Ghiran et al.   BLOOD

A New Humanized Mouse Model of Epstein‐Barr Virus Infection That Reproduces Persistent Infection, Lymphoproliferative Disorder, and Cell‐Mediated and Humoral Immune Responses

(2008) Misako Yajima et al.   JOURNAL OF INFECTIOUS DISEASES